Nexalin Financial Statements From 2010 to 2026

NXL Stock  USD 0.57  0.03  5.00%   
Nexalin Technology's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Nexalin Technology's valuation are provided below:
Gross Profit
109.1 K
Market Capitalization
10.6 M
Enterprise Value Revenue
48.8566
Revenue
156.9 K
Earnings Share
(0.65)
There are over one hundred nineteen available fundamental ratios for Nexalin Technology, which can be analyzed over time and compared to other ratios. We recommend to check Nexalin Technology's last-minute fundamental drivers against the all of the trends between 2010 and 2026. The value of Market Cap is estimated to slide to about 15.2 M. The Enterprise Value is projected to slide to about 15.4 M

Nexalin Technology Total Revenue

184,328

Check Nexalin Technology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nexalin Technology's main balance sheet or income statement drivers, such as Depreciation And Amortization of 18.2 K, Interest Expense of 2.7 K or Selling General Administrative of 826.6 K, as well as many indicators such as Price To Sales Ratio of 142, Dividend Yield of 0.0 or PTB Ratio of 6.54. Nexalin financial statements analysis is a perfect complement when working with Nexalin Technology Valuation or Volatility modules.
  
Build AI portfolio with Nexalin Stock
Check out the analysis of Nexalin Technology Correlation against competitors.
For more information on how to buy Nexalin Stock please use our How to buy in Nexalin Stock guide.

Nexalin Technology Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total AssetsM4.9 M1.5 M
Slightly volatile
Short and Long Term Debt Total3.8 KK624.5 K
Slightly volatile
Other Current Liabilities452.1 K449.4 K272.5 K
Slightly volatile
Total Current Liabilities467.4 K492 K1.1 M
Pretty Stable
Accounts Payable133.3 K140.4 K341 K
Pretty Stable
Cash388.9 K660.7 K220.1 K
Slightly volatile
Non Current Assets Total315.9 K300.8 K64.9 K
Slightly volatile
Cash And Short Term Investments2.6 MM1.3 M
Slightly volatile
Net Receivables10.2 K15 K7.8 K
Slightly volatile
Common Stock Shares Outstanding8.4 M10.6 M7.7 M
Slightly volatile
Liabilities And Stockholders EquityM4.9 M1.5 M
Slightly volatile
Inventory102.9 K200.8 K62.3 K
Slightly volatile
Other Current Assets175 K337.6 K97.1 K
Slightly volatile
Other Stockholder Equity80.4 M101.6 M68.3 M
Slightly volatile
Total Liabilities467.4 K492 K1.2 M
Slightly volatile
Total Current Assets2.9 M4.6 M1.4 M
Slightly volatile
Short Term Debt3.8 KK464.5 K
Slightly volatile
Common Stock16.1 K15.3 K5.8 K
Slightly volatile
Property Plant Equipment8.1 K7.7 K3.1 K
Slightly volatile
Long Term Debt30.1 K20.6 K42.2 K
Slightly volatile
Short and Long Term Debt727.5 K805 K610.9 K
Slightly volatile
Capital Stock8.1 K15.3 K5.7 K
Slightly volatile
Current Deferred Revenue74.5 K50.6 K109 K
Slightly volatile
Other Assets0.80.90.9824
Slightly volatile
Intangible Assets201.4 K299.8 K131.7 K
Slightly volatile

Nexalin Technology Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization18.2 K17.4 K3.9 K
Slightly volatile
Interest Expense2.7 K2.9 K63.4 K
Slightly volatile
Selling General Administrative826.6 K870.1 K966.1 K
Slightly volatile
Selling And Marketing Expenses6.9 M6.6 M2.2 M
Slightly volatile
Total Revenue184.3 K194 K261.2 K
Pretty Stable
Other Operating Expenses5.2 M9.1 M3.4 M
Slightly volatile
Cost Of Revenue31.3 K32.9 K160.1 K
Slightly volatile
Total Operating ExpensesM9.1 M3.2 M
Slightly volatile
Reconciled Depreciation18.2 K17.4 K3.5 K
Slightly volatile
Research DevelopmentM1.4 M452.7 K
Slightly volatile

Nexalin Technology Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation2.4 M4.1 M1.5 M
Slightly volatile
Begin Period Cash Flow700.6 K667.3 K180.7 K
Slightly volatile
Depreciation18.2 K17.4 K3.6 K
Slightly volatile
End Period Cash Flow388.9 K660.7 K220.1 K
Slightly volatile
Change To Netincome81.9 K86.2 K2.8 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio14213684.1696
Slightly volatile
Days Sales Outstanding16.2225.3914.9069
Slightly volatile
Average Payables172.3 K181.4 K390.9 K
Pretty Stable
Stock Based Compensation To Revenue13.1618.9911.4745
Slightly volatile
Capex To Depreciation24.2823.128.9258
Slightly volatile
EV To Sales13913385.72
Pretty Stable
Inventory Turnover0.230.246.2467
Slightly volatile
Days Of Inventory On Hand1.6 K1.6 K501
Slightly volatile
Payables Turnover0.310.270.4906
Slightly volatile
Sales General And Administrative To Revenue12.896.595.4824
Slightly volatile
Research And Ddevelopement To Revenue5.156.352.8164
Slightly volatile
Capex To Revenue0.930.890.3394
Slightly volatile
Cash Per Share0.250.340.1481
Slightly volatile
Days Payables Outstanding1.7 K1.8 KK
Slightly volatile
Income Quality0.430.470.3136
Slightly volatile
Intangibles To Total Assets0.03630.05560.033
Slightly volatile
Current Ratio6.856.521.9971
Slightly volatile
Receivables Turnover11.0611.6442.86
Very volatile
Capex Per Share0.0140.01340.0051
Slightly volatile
Average Receivables4.9 K5.5 KK
Slightly volatile
Revenue Per Share0.01570.01650.0344
Very volatile
Interest Debt Per Share0.00640.00680.0954
Slightly volatile
Debt To Assets0.00130.00144.7559
Slightly volatile
Operating Cycle1.7 K1.6 K516
Slightly volatile
Days Of Payables Outstanding1.7 K1.8 KK
Slightly volatile
Ebt Per Ebit1.511.132.4509
Slightly volatile
Quick Ratio6.556.231.9035
Slightly volatile
Cash Ratio0.990.950.3163
Slightly volatile
Days Of Inventory Outstanding1.6 K1.6 K501
Slightly volatile
Days Of Sales Outstanding16.2225.3914.9069
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.810.930.9915
Slightly volatile
Fixed Asset Turnover139201165
Slightly volatile
Debt Ratio0.00130.00144.7559
Slightly volatile
Price Sales Ratio14213684.1696
Slightly volatile
Asset Turnover0.04370.04591.236
Slightly volatile

Nexalin Technology Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap15.2 M29.3 M16.2 M
Very volatile
Enterprise Value15.4 M28.6 M16.6 M
Very volatile

Nexalin Fundamental Market Drivers

Nexalin Upcoming Events

25th of March 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

About Nexalin Technology Financial Statements

Nexalin Technology investors utilize fundamental indicators, such as revenue or net income, to predict how Nexalin Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue50.6 K74.5 K
Total Revenue194 K184.3 K
Cost Of Revenue32.9 K31.3 K
Stock Based Compensation To Revenue 18.99  13.16 
Sales General And Administrative To Revenue 6.59  12.89 
Research And Ddevelopement To Revenue 6.35  5.15 
Capex To Revenue 0.89  0.93 
Revenue Per Share 0.02  0.02 
Ebit Per Revenue(52.86)(55.50)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Nexalin Technology is a strong investment it is important to analyze Nexalin Technology's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nexalin Technology's future performance. For an informed investment choice regarding Nexalin Stock, refer to the following important reports:
Check out the analysis of Nexalin Technology Correlation against competitors.
For more information on how to buy Nexalin Stock please use our How to buy in Nexalin Stock guide.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexalin Technology. Anticipated expansion of Nexalin directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Nexalin Technology assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(0.65)
Revenue Per Share
0.011
Quarterly Revenue Growth
(0.50)
Return On Assets
(1.07)
Return On Equity
(1.78)
The market value of Nexalin Technology is measured differently than its book value, which is the value of Nexalin that is recorded on the company's balance sheet. Investors also form their own opinion of Nexalin Technology's value that differs from its market value or its book value, called intrinsic value, which is Nexalin Technology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nexalin Technology's market value can be influenced by many factors that don't directly affect Nexalin Technology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Nexalin Technology's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Nexalin Technology should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Nexalin Technology's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.